Romiplate®/ Nplate®, a genetically recombinant protein, stimulates platelet production via stimulation of the thrombopoietin receptors. Chronic ITP is normally treated with pharmaceuticals that improve blood platelet count by suppressing platelet destruction, but Romiplate®/ Nplate®, serves to improve platelet counts by stimulating platelet production.
This page features main products from Kyowa Kirin worldwide portfolio and may not be available in all countries or regions, or may be approved for different indications, in different dosages, or in different strengths. In general, those products are available only by prescription through local healthcare professionals.
Please visit our local country or region website for local information: